Skip to search formSkip to main contentSkip to account menu

4-hydroxymethyl ambrisentan

Known as: 4-hydroxymethylambrisentan 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PhenylpropionatesPyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects
AbstractBackground: Ambrisentan is a once-daily, endothelin (ET) type A receptor-selective antagonist approved for the treatment… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)